Dr Jennifer Stone is a commercial life sciences executive specialising in building markets, high-performing international teams and sustainable top-line growth. She joined biomodal in April 2023 to build out and lead the business development, sales and customer solutions teams to deliver on the company’s commercial growth objectives.
She joins us with over two decades of experience in the -omics space. Before joining biomodal, she was the Vice President of Segment Marketing at PacBio and part of the leadership team that led to transformative change within that organisation and ultimately the launch of the game-changing Revio long-read sequencing platform. Before PacBio, Dr. Stone held several commercial roles at Illumina, including Head of Population Genomics and Precision Medicine for the Americas and Global Head of Market Development and Segment Marketing for Oncology.
Dr. Stone has focused her career on the intersection of technology and precision health, specifically with early-mid-stage technologies as they cross the chasm into translational and applied use. Her experience, passion and customer-centric philosophy is a valuable addition to the leadership team and will help guide the organisation to achieve its commercial goals.
She holds a PhD from the University of California, Los Angeles in Human Genetics and a BS from the College of William and Mary in Chemistry and International Relations.
